Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2189]
News [5863]
Articles [114]
Editorials [31]
Conferences [184]
elearning [22]
Osimertinib granted breakthrough designation by FDA for 1st line treatment of patients with EGFRm positive NSCLC
Osimertinib granted breakthrough designation by FDA for 1st line treatment of patients with EGFRm positive NSCLC
NICE recommends access to venetoclax in England via Cancer Drugs Fund to treat most common form of adult leukaemia
NICE recommends access to venetoclax in England via Cancer Drugs Fund to treat most common form of adult leukaemia
Scientists enlist supercomputers, machine learning to automatically identify brain tumours
Scientists enlist supercomputers, machine learning to automatically identify brain tumours
Sperm banking is underutilised by adolescent and young adult cancer patients
Sperm banking is underutilised by adolescent and young adult cancer patients
Mystery of BRCA in breast cancer risk solved, 20 years after its discovery
Mystery of BRCA in breast cancer risk solved, 20 years after its discovery
Cancer cell drug addiction solved
Cancer cell drug addiction solved
Breast cancer statistics, 2017
Breast cancer statistics, 2017
New targeted alpha therapy protocol for advanced prostate cancer
New targeted alpha therapy protocol for advanced prostate cancer
Protein identified that drives initiation and growth of aggressive form of leukaemia
Protein identified that drives initiation and growth of aggressive form of leukaemia
New key regulator of acquisition of immune tolerance to tumour cells in cancer patients
New key regulator of acquisition of immune tolerance to tumour cells in cancer patients

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation